Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.46 |
| ▸ | NOS2 | P35228 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | MGAM | O43451 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 3/20 | 0.42 |
| ▸ | AR | P10275 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29955954 | 0.74 | ALDH1A1 (0.47) | CYP1A2ALDH1A1HPGDCYP3A4KDM4E | |
| Boric Acid SCHEMBL10788055 | 0.73 | AR (0.47) | NCF1CYP1A2NOS2BACE1CA12 | |
| SCHEMBL29952566 | 0.72 | ESR2 (0.52) | CYP1A2ALDH1A1HPGDGAACYP3A4 | |
| SCHEMBL31500078 | 0.72 | KDM4E (0.41) | CYP1A2BACE1NPC1RAB9AAR | |
| SCHEMBL29957945 | 0.71 | ALDH1A1 (0.47) | NPC1RAB9AALDH1A1MAPTHPGD | |
| SCHEMBL3677354 | 0.71 | ALDH1A1 (0.47) | NPC1RAB9AALDH1A1MAPTHPGD | |
| SCHEMBL28791 | 0.71 | BACE1 (0.53) | CYP1A2BACE1NPC1RAB9AALDH1A1 | |
| SCHEMBL6844399 | 0.70 | CCR1 (0.39) | RAB9AMAPTLMNACA1CA2 | |
| SCHEMBL20067383 | 0.69 | ENPP2 (0.36) | ALDH1A1ACHECA1CA2KDM4E | |
| SCHEMBL84064 | 0.69 | NCF1 (0.52) | NCF1CYP1A2NOS2BACE1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115679430-B | Titanium-aluminum composite part film removing treatment agent and titanium-aluminum composite part surface micropore treatment method | 东莞市慧泽凌化工科技有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-119684586-A | Polyether base oil and preparation method thereof | 万华化学集团股份有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-118908990-A | Fluorescence probe based on FRET, preparation method and application thereof in detecting sialic acid | 武汉大学 | 2024-11-08 | — | — | CN | claimed |
| CN-115010701-B | Preparation method of nitrogen-containing heterocyclic derivative | 浙江百可半导体材料有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-115010701-A | Preparation method of nitrogen-containing heterocyclic derivative | 浙江百可半导体材料有限公司 | 2022-09-06 | — | — | CN | claimed |
| EP-2176277-B1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | UNIV GEORGIA STATE RES FOUND (US) | 2016-02-24 | — | — | EP | claimed |
| US-9096856-B2 | Nucleotides and aptamers containing boronic acid groups having biased binding to glycosylated proteins, and uses thereof | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2015-08-04 | — | — | US | claimed |
| US-20130184160-A1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-07-18 | — | — | US | claimed |
| US-20110144187-A1 | APTAMER INHIBITION OF THROMBUS FORMATION | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION | 2011-06-16 | — | — | US | claimed |
| EP-2310054-A2 | APTAMER INHIBITION OF THROMBUS FORMATION | Georgia State University Research Foundation, Inc. (US) | 2011-04-20 | — | — | EP | claimed |
| EP-2176277-A2 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | Georgia State University Research Foundation, Inc. (US) | 2010-04-21 | — | — | EP | claimed |
| WO-2010019847-A2 | APTAMER INHIBITION OF THROMBUS FORMATION | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2010-02-18 | — | — | WO | claimed |
| WO-2009012363-A2 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) | 2009-01-22 | — | — | WO | claimed |
| CN-115679430-B | Titanium-aluminum composite part film removing treatment agent and titanium-aluminum composite part surface micropore treatment method | 东莞市慧泽凌化工科技有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-20250311533-A1 | LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE, AND THE HETEROCYCLIC COMPOUND | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-10-02 | — | — | US | disclosed |
| EP-4615523-A1 | COMPOUNDS AND THEIR USE | KING'S COLLEGE LONDON (GB) | 2025-09-17 | — | — | EP | disclosed |
| EP-0968158-A1 | METHOD OF PREPARING SUBSTITUTED INDANONES, THE SUBSTITUTED INDANONES AND METALLOCENES PREPARED THEREFROM | Basell Polyolefine GmbH (DE) | 2000-01-05 | — | — | EP | disclosed |
| EP-0966442-A1 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY | DUPHAR INTERNATIONAL RESEARCH B.V (NL) | 1999-12-29 | — | — | EP | disclosed |
| WO-1999012908-A1 | QUINOLINE AND QUINAZOLINE DERIVATIVES HAVING CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONIST ACTIVITY | DUPHAR INTERNATIONAL RESEARCH B.V. (NL) | 1999-03-18 | — | — | WO | disclosed |
| WO-1998040331-A1 | PREPARATION OF PREPARING SUBSTITUTED INDANONES | TARGOR GMBH (DE) | 1998-09-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130184160-A1 | NUCLEOTIDES AND APTAMERS CONTAINING BORONIC ACID GROUPS HAVING BIASED BINDING TO GLYCOSYLATED PROTEINS, AND USES THEREOF | TENT4A, PABPC4, NUDT21 | NCF1 2006/4885CYP1A2 4846/4885NOS2 4586/4885 |
| US-20110144187-A1 | APTAMER INHIBITION OF THROMBUS FORMATION | FGB, F13B, GP6 | NCF1 1585/4885CYP1A2 3166/4885NOS2 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.